pmc.ncbi.nlm.nih.gov

Oral shedding of herpes simplex virus type 2

Abstract

Objectives: Herpes simplex virus (HSV) 1 and HSV-2 reactivate preferentially in the oral and genital area, respectively. We aimed to define frequency and characteristics associated with oral shedding of HSV-2.

Methods: Demographic, clinical and laboratory data of patients with documented HSV-2 infection and at least one oral viral culture obtained were selected from the University of Washington Virology Research Clinic database.

Results: Of 1388 people meeting the entry criteria, 44 (3.2%) had HSV-2 isolated at least once from their mouths. In comparison with the 1344 people who did not have HSV-2 isolated from their mouth, participants with oral HSV-2 were more likely to be male (OR = 1.9, 95% CI 1.0 to 3.7), HIV positive (OR = 2.9, 95% CI 1.4 to 6.0), and homosexual (OR = 2.2, 95% CI 1.1 to 4.2), and to have collected a larger number of oral specimens (median 32 v 4, p<0.001). Of the 58 days with oral HSV-2 isolation, 15 (25%) occurred during newly acquired HSV-2 infection, 12 (21%) during a recurrence with genital lesions, three (5%) during a recurrence with oral lesions, and three (5%) during a recurrence with oral and genital lesions; 25 (43%) occurred during asymptomatic shedding. Oral HSV-2 was found less frequently than oral HSV-1 (0.06% v 1%, p<0.001) in people with HSV-1 and HSV-2 antibody, and less frequently than genital HSV-2 (0.09% v 7%, p<0.001).

Conclusions: Oral reactivation of HSV-2 as defined by viral isolation is uncommon and usually occurs in the setting of first episode of genital HSV-2 or during genital recurrence of HSV-2.

Full Text

The Full Text of this article is available as a PDF (779.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley R. L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. doi: 10.1128/jcm.26.4.662-667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brock B. V., Selke S., Benedetti J., Douglas J. M., Jr, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA. 1990 Jan 19;263(3):418–420. [PubMed] [Google Scholar]
  3. Corey L., Holmes K. K. Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med. 1983 Jun;98(6):973–983. doi: 10.7326/0003-4819-98-6-973. [DOI] [PubMed] [Google Scholar]
  4. Docherty J. J., Trimble J. J., Roman S. R., Faulkner S. C., Naugle F. P., Mundon F. K., Zimmerman D. H. Lack of oral HSV-2 in a college student population. J Med Virol. 1985 Jul;16(3):283–287. doi: 10.1002/jmv.1890160309. [DOI] [PubMed] [Google Scholar]
  5. Husak R., Tebbe B., Goerdt S., Wölfer L. U., Zeichardt H., Stöffler-Meilicke M., Orfanos C. E. Pseudotumour of the tongue caused by herpes simplex virus type 2 in an HIV-1 infected immunosuppressed patient. Br J Dermatol. 1998 Jul;139(1):118–121. doi: 10.1046/j.1365-2133.1998.02327.x. [DOI] [PubMed] [Google Scholar]
  6. Krone M. R., Tabet S. R., Paradise M., Wald A., Corey L., Celum C. L. Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: site and frequency of shedding. J Infect Dis. 1998 Oct;178(4):978–982. doi: 10.1086/515666. [DOI] [PubMed] [Google Scholar]
  7. Krone M. R., Wald A., Tabet S. R., Paradise M., Corey L., Celum C. L. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis. 2000 Feb;30(2):261–267. doi: 10.1086/313647. [DOI] [PubMed] [Google Scholar]
  8. Lafferty W. E., Coombs R. W., Benedetti J., Critchlow C., Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987 Jun 4;316(23):1444–1449. doi: 10.1056/NEJM198706043162304. [DOI] [PubMed] [Google Scholar]
  9. Lafferty W. E., Downey L., Celum C., Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 2000 Apr 13;181(4):1454–1457. doi: 10.1086/315395. [DOI] [PubMed] [Google Scholar]
  10. Langenberg A., Zbanyszek R., Dragavon J., Ashley R., Corey L. Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol. 1988 Sep;26(9):1772–1774. doi: 10.1128/jcm.26.9.1772-1774.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Löwhagen G. B., Tunbäck P., Andersson K., Bergström T., Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect. 2000 Jun;76(3):179–182. doi: 10.1136/sti.76.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MacPhail L. A., Greenspan D., Schiødt M., Drennan D. P., Mills J. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS. Oral Surg Oral Med Oral Pathol. 1989 Apr;67(4):427–432. doi: 10.1016/0030-4220(89)90386-1. [DOI] [PubMed] [Google Scholar]
  13. Mertz G. J. Genital herpes simplex virus infections. Med Clin North Am. 1990 Nov;74(6):1433–1454. doi: 10.1016/s0025-7125(16)30489-8. [DOI] [PubMed] [Google Scholar]
  14. Straus S. E., Rooney J. F., Hallahan C. Acyclovir suppresses subclinical shedding of herpes simplex virus. Ann Intern Med. 1996 Nov 1;125(9):776–777. doi: 10.7326/0003-4819-125-9-199611010-00015. [DOI] [PubMed] [Google Scholar]
  15. Vyse A. J., Gay N. J., Slomka M. J., Gopal R., Gibbs T., Morgan-Capner P., Brown D. W. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000 Jun;76(3):183–187. doi: 10.1136/sti.76.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wald A., Zeh J., Selke S., Ashley R. L., Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med. 1995 Sep 21;333(12):770–775. doi: 10.1056/NEJM199509213331205. [DOI] [PubMed] [Google Scholar]
  17. Wald A., Zeh J., Selke S., Warren T., Ryncarz A. J., Ashley R., Krieger J. N., Corey L. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000 Mar 23;342(12):844–850. doi: 10.1056/NEJM200003233421203. [DOI] [PubMed] [Google Scholar]
  18. Wolff Manfred H., Schmitt Judith, Rahaus Markus, Dudda Hans, Hatzmann Wolfgang. Clinical and subclinical reactivation of genital herpes virus. Intervirology. 2002;45(1):20–23. doi: 10.1159/000050083. [DOI] [PubMed] [Google Scholar]
  19. Yoshikawa T., Hill J. M., Stanberry L. R., Bourne N., Kurawadwala J. F., Krause P. R. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med. 1996 Aug 1;184(2):659–664. doi: 10.1084/jem.184.2.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yura Y., Iga H., Kondo Y., Harada K., Yanagawa T., Yoshida H., Sato M. Herpes simplex virus type 1 and type 2 infection in human oral mucosa in culture. J Oral Pathol Med. 1991 Feb;20(2):68–73. doi: 10.1111/j.1600-0714.1991.tb00892.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Erratum - corrected Table 4]